1 Min Read
March 7 (Reuters) - Merck KGaA:
* MERCK KGAA, DARMSTADT, GERMANY, ANNOUNCES POSITIVE PHASE IIB RESULTS FOR EVOBRUTINIB IN RELAPSING MULTIPLE SCLEROSIS
* MERCK KGAA - STUDY HAS MET ITS PRIMARY ENDPOINT Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.